Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 2,233 | reported | 15 Jun 2026 | tx 9+29,381−8,141 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jun 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 2,954 | 62.08 USD | 10b5-1 |
| 12 Jun 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 2,954 | — | |
| 12 Jun 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 2,954 | 0.00 USD | deriv |
| 15 Dec 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 2,233 | — | |
| 15 Dec 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 2,233 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 4,540 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 2,954 | 0.00 USD | deriv |
| 13 Nov 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 6,700 | 0.00 USD | deriv |
| 13 Nov 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |